Literature DB >> 3544338

Structure-function relationships of phospholipases. II: Charge density distribution and the myotoxicity of presynaptically neurotoxic phospholipases.

R M Kini, S Iwanaga.   

Abstract

The charge density distribution of 24 phospholipases A2 has been examined to identify the involvement of charged amino acid residues in the determination of the pharmacological properties of these proteins. There is no characteristic difference between the presynaptically neurotoxic and non-neurotoxic phospholipases, however, presynaptically neurotoxic phospholipases which are also myotoxic have a distinct charge distribution pattern. There is a characteristic cationic site around residues 79-87. This site has a relatively fixed position with respect to the hydrophobic 'neurotoxic' region, on the NH2 terminal side. This cationic region is located on the outer surface in the three-dimensional structure of phospholipase, just before hydrophobic helix E, and is available for interaction with membranes. Such a characteristic region is absent in non-myotoxic phospholipases which are either presynaptically active or inactive. On the other hand, myotoxins, a group of non-enzymatic proteins inducing myotoxicity, also possess such characteristic regions of cationic and hydrophobic sites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3544338     DOI: 10.1016/0041-0101(86)90090-5

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  12 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced rhabdomyolysis.

Authors:  C Köppel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

2.  Determination of primary structure of two isoforms 6-1 and 6-2 PLA2 D49 from Bothrops jararacussu snake venom and neurotoxic characterization using in vitro neuromuscular preparation.

Authors:  L A Ponce-Soto; V L Bonfim; L Rodrigues-Simioni; J C Novello; S Marangoni
Journal:  Protein J       Date:  2006-02       Impact factor: 2.371

3.  Structural and phylogenetic basis for the classification of group III phospholipase A2.

Authors:  Gururao Hariprasad; Alagiri Srinivasan; Reema Singh
Journal:  J Mol Model       Date:  2013-06-23       Impact factor: 1.810

4.  Antibodies to a phospholipase A2 from Vipera russelli selectively neutralize venom neurotoxicity.

Authors:  S Kasturi; L M Rudrammaji; T V Gowda
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

5.  The molecular cloning of a phospholipase A2 from Bothrops jararacussu snake venom: evolution of venom group II phospholipase A2's may imply gene duplications.

Authors:  A M Moura-da-Silva; M J Paine; M R Diniz; R D Theakston; J M Crampton
Journal:  J Mol Evol       Date:  1995-08       Impact factor: 2.395

6.  Coralsnake Venomics: Analyses of Venom Gland Transcriptomes and Proteomes of Six Brazilian Taxa.

Authors:  Steven D Aird; Nelson Jorge da Silva; Lijun Qiu; Alejandro Villar-Briones; Vera Aparecida Saddi; Mariana Pires de Campos Telles; Miguel L Grau; Alexander S Mikheyev
Journal:  Toxins (Basel)       Date:  2017-06-08       Impact factor: 4.546

7.  Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid.

Authors:  B S Vishwanath; A A Fawzy; R C Franson
Journal:  Inflammation       Date:  1988-12       Impact factor: 4.092

8.  Crystallization and preliminary X-ray diffraction analysis of a novel Arg49 phospholipase A2 homologue from Zhaoermia mangshanensis venom.

Authors:  Mário T Murakami; Ulrich Kuch; Dietrich Mebs; Raghuvir K Arni
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-06-22

9.  Biochemical, pharmacological and structural characterization of two PLA2 isoforms Cdr-12 and Cdr-13 from Crotalus durissus ruruima snake venom.

Authors:  Luis Alberto Ponce-Soto; Paulo Aparecido Baldasso; Frey Francisco Romero-Vargas; Flávia V Winck; José Camillo Novello; Sergio Marangoni
Journal:  Protein J       Date:  2007-01       Impact factor: 4.000

10.  Biochemical characterization and pharmacological properties of new basic PLA2 BrTX-I isolated from Bothrops roedingeri (Roedinger's Lancehead) Mertens, 1942, snake venom.

Authors:  Mauricio Aurelio Gomes Heleno; Paulo Aparecido Baldasso; Luis Alberto Ponce-Soto; Sérgio Marangoni
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.